Lawmakers, Drug Makers Spar Over Pharma Patent Settlements (Nasdaq)
Lawmakers, Drug Makers Spar Over Pharma Patent Settlements (Nasdaq)
WASHINGTON -(Dow Jones)- Executives for Mylan Inc. (MYL) and Endo Pharmaceuticals Inc. (ENDP) faced a grilling on Capitol Hill Wednesday from lawmakers who support legislation to bar pharmaceutical patent settlements that delay the introduction of generic drugs.